The Food and Drug Administration has approved the drug dapagliflozin that helps in improving glycemic control in patients with Type 2 diabetes. The drug is the second of a new class of medications and will be marketed under the name Farxiga.
Researchers found that exercise could alleviate joint pain in breast cancer patients who take aromatase inhibitors.
Researchers reported that some diabetes drugs could reduce the risk of cancer in women.
A federal report stated that teenage Ecstasy use is on the rise in the U.S.
The U.S. Food and Drug Administration has approved the use of anti-cancer drug Nexavar (sorafenib) for late-stage differentiated thyroid cancer. The type is one of the most common kinds of thyroid cancer.
Researchers at Kaiser Permanente found that diabetics who used mail order pharmacies visited the ER a lot less than diabetics who picked up their prescriptions in person.
Researchers reported that medication combined with psychotherapy can help reduce or delay relapse.
Two Harvard doctors stated that the new calculator that was created to estimate people's heart disease risk is flawed.
Students use prescription medication and drugs to enhance their reasoning performance, research finds.
Nicotine withdrawal affects a very specific group of neurons within a very specific brain region, according to a new study.
Quitting drugs "cold turkey" can trigger mental decline, according to a new study.
Researchers stated that the wider definition for ADHD could lead to more diagnoses and unnecessary medical treatment.
Johnson & Johnson has settled with the U.S. government and agreed to pay $2.2 billion.
The FDA's new proposal will require drug companies that make life-saving drugs to inform the agency of any potential changes that could affect the U.S. supply six months prior to the changes.
Researchers found that children who were exposed to cortisol-like drugs in the womb might have a higher risk of emotional disorders.
Researchers from the University of Sheffield School of Health and Related Research (ScHARR) are today making a series of recommendations for NHS mental health trusts to change the way they collect and use patient feedback to improve the quality of care for inpatients.